Heron Therapeutics, Inc. /De/ (HRTX)Rubric Capital Management LP added to its stake +2.39M shares
Rubric Capital Management LP added to its stake in Heron Therapeutics, Inc. /De/, per its Q3 2025 13F.
- 29.1M
- Shares reported · +2.39M vs prior quarter
- 0.41%
- Disclosed portfolio weight
- $36.7M
- Reported value
- Holdings as of
- Sep 30, 2025
- Filed
- Nov 14, 2025
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Oct 27, 2025Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On October 27, 2025, the Board of Directors (the “Board”) of Heron Therapeutics, Inc. (the “Company”) appointed Thomas Cusack to the Board to serve for a term expiring at the Company’s 2026 Annual Meeting of Stockholders and until his successor is duly elected and qualified or until his earlier death, resignation or removal.”
- Nov 4, 2025Company filing · Form 8-K · ResultsReported its results
What came next
How to read SEC Form 13F-HR
Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.
Full guide: What is an SEC Form 13F?
What else is on file for Heron Therapeutics, Inc. /De/
OQRO holds no insider, Congress, fund or contract record for Heron Therapeutics, Inc. /De/ dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its HRTX page.
How this filing works
Other disclosures at Heron Therapeutics, Inc. /De/
- SEC Form 13F-HRFeb 13, 2026
- SEC Form 4Aug 12, 2025
- SEC Form 4Aug 12, 2025
- SEC Form 13F-HRNov 14, 2024
- House Clerk periodic transaction reportApr 5, 2021
Everything OQRO holds on this company is on its HRTX page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO Pro is a paid subscription. You see the price before you pay
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data